2015-2025 Global Radiopharmaceuticals in Nuclear Medicine Market Research by Type, End-Use and Region (COVID-19 Version)

July 2020 | 161 pages | ID: 20D1D45B8D75EN
99Strategy

Abstracts

SUMMARY

The global Radiopharmaceuticals in Nuclear Medicine market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:

• Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
• Chapter 2: Global Production & Consumption Market by Type and End-Use
• Chapter 3: Europe Production & Consumption Market by Type and End-Use
• Chapter 4: America Production & Consumption Market by Type and End-Use
• Chapter 5: Asia Production & Consumption Market by Type and End-Use
• Chapter 6: Oceania Production & Consumption Market by Type and End-Use
• Chapter 7: Africa Production & Consumption Market by Type and End-Use
• Chapter 8: Global Market Forecast by Type, End-Use and Region
• Chapter 9: Company information, Sales, Cost, Margin, news etc.
• Chapter 10: Market Competition by Companies and Market Concentration Ratio
• Chapter 11: Market Impact by Coronavirus.
• Chapter 12: Industry Summary

Market Segment as follows:

Key Companies

• Bracco Imaging S.P.A.
• Cambridge Isotope Laboratories, Inc.
• Cardinal Health, Inc.
• Covidien, Plc
• Eczacibasi-Monrol
• Fujifilm Holdings Corporation
• GE Healthcare (Subsidiary Of General Electric Company)
• IBA Group
• Isotec, Inc. (Sigma-Aldrich)
• Lantheus Medical Imaging, Inc.
• Nordion, Inc.
• Ntp Radioisotopes (Pty), Ltd.
• Siemens Healthcare (Subsidiary Of Siemens AG)
• Taiyo Nippon Sanso Corporation
• Urenco Limited
• Rotem Industries, Ltd., Inc.
• Australian Nuclear Association And Technology Organization (ANSTO)
• Board of Radiation And Isotope Technology (BRIT)
• Institute of Atomic Energy Polatom Radioisotope Centre
• Institute of Isotopes Co., Ltd.
• Institute Of Radioelement (IRE)

Key Types

• Diagnostic Radiopharmaceuticals
• Therapy Radiopharmaceuticals
• Enriched Stable Isotopes

Key End-Use

• Diagnostic Application
• Therapeutic Application
• Research
• Pharmaceutical
• Others

This report can be dispatched within 24-48 Hours.

Contents

CHAPTER 1 MARKET OVERVIEW

1.1 Market Definition and Segment
  1.1.1 Product Definition
  1.1.2 Product Type
  1.1.3 End-Use
  1.1.4 Marketing Channel
1.2 Major Regions
  1.2.1 Europe Market Size and Growth
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.2 America Market Size and Growth
Figure America Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Radiopharmaceuticals in Nuclear Medicine Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.3 Asia Market Size and Growth
Figure Asia Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaRadiopharmaceuticals in Nuclear Medicine Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.4 Oceania Market Size and Growth
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.5 Africa Market Size and Growth
Figure Africa Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast and Growth Rate, 2020E-2025F (Million USD)

CHAPTER 2 GLOBAL MARKET SEGMENTATION

2.1 Global Production Overview
Table Global Radiopharmaceuticals in Nuclear Medicine Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type, 2015-2020 (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type in 2020 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Production Volume by Type, 2015-2020 (Volume)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region, 2015-2020 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 3 EUROPE MARKET SEGMENTATION

3.1 Europe Production Overview
Table Europe Radiopharmaceuticals in Nuclear Medicine Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Type, 2015-2020 (Million USD)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type in 2020 (Million USD)
Table Europe Radiopharmaceuticals in Nuclear Medicine Production Volume by Type, 2015-2020 (Volume)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 4 AMERICA MARKET SEGMENTATION

4.1 America Production Overview
Table America Radiopharmaceuticals in Nuclear Medicine Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Radiopharmaceuticals in Nuclear Medicine Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Radiopharmaceuticals in Nuclear Medicine Revenue by Type, 2015-2020 (Million USD)
Figure America Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type in 2020 (Million USD)
Table America Radiopharmaceuticals in Nuclear Medicine Production Volume by Type, 2015-2020 (Volume)
Figure America Radiopharmaceuticals in Nuclear Medicine Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Radiopharmaceuticals in Nuclear Medicine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Radiopharmaceuticals in Nuclear Medicine Consumption Value Share by End-Use in 2020 (Million USD)
Table America Radiopharmaceuticals in Nuclear Medicine Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Radiopharmaceuticals in Nuclear Medicine Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region, 2015-2020 (Million USD)
Table America Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 5 ASIA MARKET SEGMENTATION

5.1 Asia Production Overview
Table Asia Radiopharmaceuticals in Nuclear Medicine Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Radiopharmaceuticals in Nuclear Medicine Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Radiopharmaceuticals in Nuclear Medicine Revenue by Type, 2015-2020 (Million USD)
Figure Asia Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type in 2020 (Million USD)
Table Asia Radiopharmaceuticals in Nuclear Medicine Production Volume by Type, 2015-2020 (Volume)
Figure Asia Radiopharmaceuticals in Nuclear Medicine Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Radiopharmaceuticals in Nuclear Medicine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Radiopharmaceuticals in Nuclear Medicine Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Radiopharmaceuticals in Nuclear Medicine Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Radiopharmaceuticals in Nuclear Medicine Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 6 OCEANIA MARKET SEGMENTATION

6.1 Oceania Production Overview
Table Oceania Radiopharmaceuticals in Nuclear Medicine Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Radiopharmaceuticals in Nuclear Medicine Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type in 2020 (Million USD)
Table Oceania Radiopharmaceuticals in Nuclear Medicine Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 7 AFRICA MARKET SEGMENTATION

7.1 Africa Production Overview
Table Africa Radiopharmaceuticals in Nuclear Medicine Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Radiopharmaceuticals in Nuclear Medicine Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Type, 2015-2020 (Million USD)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type in 2020 (Million USD)
Table Africa Radiopharmaceuticals in Nuclear Medicine Production Volume by Type, 2015-2020 (Volume)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Radiopharmaceuticals in Nuclear Medicine Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Radiopharmaceuticals in Nuclear Medicine Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 8 GLOBAL MARKET FORECAST

8.1 Global Radiopharmaceuticals in Nuclear Medicine Production Forecast
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Radiopharmaceuticals in Nuclear Medicine Forecast by Type
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type, 2020E-2025F (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type in 2025 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Production Volume by Type, 2020E-2025F (Volume)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Volume Share by Type in 2025 (Volume)
8.3 Global Radiopharmaceuticals in Nuclear Medicine Forecast by End-Use (2020E-2025F)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Radiopharmaceuticals in Nuclear Medicine Forecast by Region (2020E-2025F)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Value Share by Region in 2025 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume Share by Region in 2025 (Volume)

CHAPTER 9 GLOBAL MAJOR COMPANIES LIST

9.1 Bracco Imaging S.P.A.
  9.1.1 Bracco Imaging S.P.A. Profile
Table Bracco Imaging S.P.A. Overview List
  9.1.2 Bracco Imaging S.P.A. Products & Services
  9.1.3 Bracco Imaging S.P.A. Company Dynamics & News
  9.1.4 Bracco Imaging S.P.A. Business Operation Conditions
Table Business Operation of Bracco Imaging S.P.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Cambridge Isotope Laboratories, Inc.
  9.2.1 Cambridge Isotope Laboratories, Inc. Profile
Table Cambridge Isotope Laboratories, Inc. Overview List
  9.2.2 Cambridge Isotope Laboratories, Inc. Products & Services
  9.2.3 Cambridge Isotope Laboratories, Inc. Company Dynamics & News
  9.2.4 Cambridge Isotope Laboratories, Inc. Business Operation Conditions
Table Business Operation of Cambridge Isotope Laboratories, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Cardinal Health, Inc.
  9.3.1 Cardinal Health, Inc. Profile
Table Cardinal Health, Inc. Overview List
  9.3.2 Cardinal Health, Inc. Products & Services
  9.3.3 Cardinal Health, Inc. Company Dynamics & News
  9.3.4 Cardinal Health, Inc. Business Operation Conditions
Table Business Operation of Cardinal Health, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Covidien, Plc
  9.4.1 Covidien, Plc Profile
Table Covidien, Plc Overview List
  9.4.2 Covidien, Plc Products & Services
  9.4.3 Covidien, Plc Company Dynamics & News
  9.4.4 Covidien, Plc Business Operation Conditions
Table Business Operation of Covidien, Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Eczacibasi-Monrol
  9.5.1 Eczacibasi-Monrol Profile
Table Eczacibasi-Monrol Overview List
  9.5.2 Eczacibasi-Monrol Products & Services
  9.5.3 Eczacibasi-Monrol Company Dynamics & News
  9.5.4 Eczacibasi-Monrol Business Operation Conditions
Table Business Operation of Eczacibasi-Monrol (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Fujifilm Holdings Corporation
  9.6.1 Fujifilm Holdings Corporation Profile
Table Fujifilm Holdings Corporation Overview List
  9.6.2 Fujifilm Holdings Corporation Products & Services
  9.6.3 Fujifilm Holdings Corporation Company Dynamics & News
  9.6.4 Fujifilm Holdings Corporation Business Operation Conditions
Table Business Operation of Fujifilm Holdings Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 GE Healthcare (Subsidiary Of General Electric Company)
  9.7.1 GE Healthcare (Subsidiary Of General Electric Company) Profile
Table GE Healthcare (Subsidiary Of General Electric Company) Overview List
  9.7.2 GE Healthcare (Subsidiary Of General Electric Company) Products & Services
  9.7.3 GE Healthcare (Subsidiary Of General Electric Company) Company Dynamics & News
  9.7.4 GE Healthcare (Subsidiary Of General Electric Company) Business Operation Conditions
Table Business Operation of GE Healthcare (Subsidiary Of General Electric Company) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 IBA Group
  9.8.1 IBA Group Profile
Table IBA Group Overview List
  9.8.2 IBA Group Products & Services
  9.8.3 IBA Group Company Dynamics & News
  9.8.4 IBA Group Business Operation Conditions
Table Business Operation of IBA Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Isotec, Inc. (Sigma-Aldrich)
  9.9.1 Isotec, Inc. (Sigma-Aldrich) Profile
Table Isotec, Inc. (Sigma-Aldrich) Overview List
  9.9.2 Isotec, Inc. (Sigma-Aldrich) Products & Services
  9.9.3 Isotec, Inc. (Sigma-Aldrich) Company Dynamics & News
  9.9.4 Isotec, Inc. (Sigma-Aldrich) Business Operation Conditions
Table Business Operation of Isotec, Inc. (Sigma-Aldrich) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Lantheus Medical Imaging, Inc.
  9.10.1 Lantheus Medical Imaging, Inc. Profile
Table Lantheus Medical Imaging, Inc. Overview List
  9.10.2 Lantheus Medical Imaging, Inc. Products & Services
  9.10.3 Lantheus Medical Imaging, Inc. Company Dynamics & News
  9.10.4 Lantheus Medical Imaging, Inc. Business Operation Conditions
Table Business Operation of Lantheus Medical Imaging, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Nordion, Inc.
  9.11.1 Nordion, Inc. Profile
Table Nordion, Inc. Overview List
  9.11.2 Nordion, Inc. Products & Services
  9.11.3 Nordion, Inc. Company Dynamics & News
  9.11.4 Nordion, Inc. Business Operation Conditions
Table Business Operation of Nordion, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Ntp Radioisotopes (Pty), Ltd.
  9.12.1 Ntp Radioisotopes (Pty), Ltd. Profile
Table Ntp Radioisotopes (Pty), Ltd. Overview List
  9.12.2 Ntp Radioisotopes (Pty), Ltd. Products & Services
  9.12.3 Ntp Radioisotopes (Pty), Ltd. Company Dynamics & News
  9.12.4 Ntp Radioisotopes (Pty), Ltd. Business Operation Conditions
Table Business Operation of Ntp Radioisotopes (Pty), Ltd. (Sales Revenue, Cost, Gross Margin)
9.13 Siemens Healthcare (Subsidiary Of Siemens AG)
  9.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Profile
Table Siemens Healthcare (Subsidiary Of Siemens AG) Overview List
  9.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Products & Services
  9.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Company Dynamics & News
  9.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Business Operation Conditions
Table Business Operation of Siemens Healthcare (Subsidiary Of Siemens AG) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Taiyo Nippon Sanso Corporation
  9.14.1 Taiyo Nippon Sanso Corporation Profile
Table Taiyo Nippon Sanso Corporation Overview List
  9.14.2 Taiyo Nippon Sanso Corporation Products & Services
  9.14.3 Taiyo Nippon Sanso Corporation Company Dynamics & News
  9.14.4 Taiyo Nippon Sanso Corporation Business Operation Conditions
Table Business Operation of Taiyo Nippon Sanso Corporation (Sales Revenue, Cost, Gross Margin)
9.15 Urenco Limited
  9.15.1 Urenco Limited Profile
Table Urenco Limited Overview List
  9.15.2 Urenco Limited Products & Services
  9.15.3 Urenco Limited Company Dynamics & News
  9.15.4 Urenco Limited Business Operation Conditions
Table Business Operation of Urenco Limited (Sales Revenue, Cost, Gross Margin)
9.16 Rotem Industries, Ltd., Inc.
  9.16.1 Rotem Industries, Ltd., Inc. Profile
Table Rotem Industries, Ltd., Inc. Overview List
  9.16.2 Rotem Industries, Ltd., Inc. Products & Services
  9.16.3 Rotem Industries, Ltd., Inc. Company Dynamics & News
  9.16.4 Rotem Industries, Ltd., Inc. Business Operation Conditions
Table Business Operation of Rotem Industries, Ltd., Inc. (Sales Revenue, Cost, Gross Margin)
9.17 Australian Nuclear Association And Technology Organization (ANSTO)
  9.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Profile
Table Australian Nuclear Association And Technology Organization (ANSTO) Overview List
  9.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Products & Services
  9.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Company Dynamics & News
  9.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Business Operation Conditions
Table Business Operation of Australian Nuclear Association And Technology Organization (ANSTO) (Sales Revenue, Cost, Gross Margin)
9.18 Board of Radiation And Isotope Technology (BRIT)
  9.18.1 Board of Radiation And Isotope Technology (BRIT) Profile
Table Board of Radiation And Isotope Technology (BRIT) Overview List
  9.18.2 Board of Radiation And Isotope Technology (BRIT) Products & Services
  9.18.3 Board of Radiation And Isotope Technology (BRIT) Company Dynamics & News
  9.18.4 Board of Radiation And Isotope Technology (BRIT) Business Operation Conditions
Table Business Operation of Board of Radiation And Isotope Technology (BRIT) (Sales Revenue, Cost, Gross Margin)
9.19 Institute of Atomic Energy Polatom Radioisotope Centre
  9.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Profile
Table Institute of Atomic Energy Polatom Radioisotope Centre Overview List
  9.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Products & Services
  9.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Company Dynamics & News
  9.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Business Operation Conditions
Table Business Operation of Institute of Atomic Energy Polatom Radioisotope Centre (Sales Revenue, Cost, Gross Margin)
9.20 Institute of Isotopes Co., Ltd.
  9.20.1 Institute of Isotopes Co., Ltd. Profile
Table Institute of Isotopes Co., Ltd. Overview List
  9.20.2 Institute of Isotopes Co., Ltd. Products & Services
  9.20.3 Institute of Isotopes Co., Ltd. Company Dynamics & News
  9.20.4 Institute of Isotopes Co., Ltd. Business Operation Conditions
Table Business Operation of Institute of Isotopes Co., Ltd. (Sales Revenue, Cost, Gross Margin)
9.21 Institute Of Radioelement (IRE)
  9.21.1 Institute Of Radioelement (IRE) Profile
Table Institute Of Radioelement (IRE) Overview List
  9.21.2 Institute Of Radioelement (IRE) Products & Services
  9.21.3 Institute Of Radioelement (IRE) Company Dynamics & News
  9.21.4 Institute Of Radioelement (IRE) Business Operation Conditions
Table Business Operation of Institute Of Radioelement (IRE) (Sales Revenue, Cost, Gross Margin)

PART 10 MARKET COMPETITION

10.1 Key Company Market Share
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume by Companies, 2015-2020E (Volume)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Concentration Ratio in 2020E
Figure America Radiopharmaceuticals in Nuclear Medicine Market Concentration Ratio in 2020E
Figure Asia Radiopharmaceuticals in Nuclear Medicine Market Concentration Ratio in 2020E
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Market Concentration Ratio in 2020E
Figure Africa Radiopharmaceuticals in Nuclear Medicine Market Concentration Ratio in 2020E

PART 11 CORONAVIRUS IMPACT ON RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE INDUSTRY

11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment

PART 12 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE INDUSTRY SUMMARY & CONCLUSION

List Of Tables

LIST OF TABLES
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type, 2015-2020 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Production Volume by Type, 2015-2020 (Volume)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region, 2015-2020 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Radiopharmaceuticals in Nuclear Medicine Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Type, 2015-2020 (Million USD)
Table Europe Radiopharmaceuticals in Nuclear Medicine Production Volume by Type, 2015-2020 (Volume)
Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Region, 2015-2020 (Volume)
Table America Radiopharmaceuticals in Nuclear Medicine Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Radiopharmaceuticals in Nuclear Medicine Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Radiopharmaceuticals in Nuclear Medicine Revenue by Type, 2015-2020 (Million USD)
Table America Radiopharmaceuticals in Nuclear Medicine Production Volume by Type, 2015-2020 (Volume)
Table America Radiopharmaceuticals in Nuclear Medicine Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Radiopharmaceuticals in Nuclear Medicine Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region, 2015-2020 (Million USD)
Table America Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Radiopharmaceuticals in Nuclear Medicine Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Radiopharmaceuticals in Nuclear Medicine Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Radiopharmaceuticals in Nuclear Medicine Revenue by Type, 2015-2020 (Million USD)
Table Asia Radiopharmaceuticals in Nuclear Medicine Production Volume by Type, 2015-2020 (Volume)
Table Asia Radiopharmaceuticals in Nuclear Medicine Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Radiopharmaceuticals in Nuclear Medicine Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Radiopharmaceuticals in Nuclear Medicine Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Radiopharmaceuticals in Nuclear Medicine Revenue by Type, 2015-2020 (Million USD)
Table Oceania Radiopharmaceuticals in Nuclear Medicine Production Volume by Type, 2015-2020 (Volume)
Table Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Radiopharmaceuticals in Nuclear Medicine Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Radiopharmaceuticals in Nuclear Medicine Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Type, 2015-2020 (Million USD)
Table Africa Radiopharmaceuticals in Nuclear Medicine Production Volume by Type, 2015-2020 (Volume)
Table Africa Radiopharmaceuticals in Nuclear Medicine Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Radiopharmaceuticals in Nuclear Medicine Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Region, 2015-2020 (Volume)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type, 2020E-2025F (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Production Volume by Type, 2020E-2025F (Volume)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Region, 2020E-2025F (Volume)
Table Bracco Imaging S.P.A. Overview List
Table Business Operation of Bracco Imaging S.P.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cambridge Isotope Laboratories, Inc. Overview List
Table Business Operation of Cambridge Isotope Laboratories, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cardinal Health, Inc. Overview List
Table Business Operation of Cardinal Health, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Covidien, Plc Overview List
Table Business Operation of Covidien, Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eczacibasi-Monrol Overview List
Table Business Operation of Eczacibasi-Monrol (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Fujifilm Holdings Corporation Overview List
Table Business Operation of Fujifilm Holdings Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GE Healthcare (Subsidiary Of General Electric Company) Overview List
Table Business Operation of GE Healthcare (Subsidiary Of General Electric Company) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table IBA Group Overview List
Table Business Operation of IBA Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Isotec, Inc. (Sigma-Aldrich) Overview List
Table Business Operation of Isotec, Inc. (Sigma-Aldrich) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Lantheus Medical Imaging, Inc. Overview List
Table Business Operation of Lantheus Medical Imaging, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nordion, Inc. Overview List
Table Business Operation of Nordion, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ntp Radioisotopes (Pty), Ltd. Overview List
Table Business Operation of Ntp Radioisotopes (Pty), Ltd. (Sales Revenue, Cost, Gross Margin)
Table Siemens Healthcare (Subsidiary Of Siemens AG) Overview List
Table Business Operation of Siemens Healthcare (Subsidiary Of Siemens AG) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Taiyo Nippon Sanso Corporation Overview List
Table Business Operation of Taiyo Nippon Sanso Corporation (Sales Revenue, Cost, Gross Margin)
Table Urenco Limited Overview List
Table Business Operation of Urenco Limited (Sales Revenue, Cost, Gross Margin)
Table Rotem Industries, Ltd., Inc. Overview List
Table Business Operation of Rotem Industries, Ltd., Inc. (Sales Revenue, Cost, Gross Margin)
Table Australian Nuclear Association And Technology Organization (ANSTO) Overview List
Table Business Operation of Australian Nuclear Association And Technology Organization (ANSTO) (Sales Revenue, Cost, Gross Margin)
Table Board of Radiation And Isotope Technology (BRIT) Overview List
Table Business Operation of Board of Radiation And Isotope Technology (BRIT) (Sales Revenue, Cost, Gross Margin)
Table Institute of Atomic Energy Polatom Radioisotope Centre Overview List
Table Business Operation of Institute of Atomic Energy Polatom Radioisotope Centre (Sales Revenue, Cost, Gross Margin)
Table Institute of Isotopes Co., Ltd. Overview List
Table Business Operation of Institute of Isotopes Co., Ltd. (Sales Revenue, Cost, Gross Margin)
Table Institute Of Radioelement (IRE) Overview List
Table Business Operation of Institute Of Radioelement (IRE) (Sales Revenue, Cost, Gross Margin)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume by Companies, 2015-2020E (Volume)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Share by Companies, 2015-2020E (Volume)

List Of Figures

LIST OF FIGURES
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Radiopharmaceuticals in Nuclear Medicine Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaRadiopharmaceuticals in Nuclear Medicine Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type in 2020 (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Volume Share by Type in 2020 (Volume)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type in 2020 (Million USD)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Production Volume Share by Type in 2020 (Volume)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type in 2020 (Million USD)
Figure America Radiopharmaceuticals in Nuclear Medicine Production Volume Share by Type in 2020 (Volume)
Figure America Radiopharmaceuticals in Nuclear Medicine Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Radiopharmaceuticals in Nuclear Medicine Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type in 2020 (Million USD)
Figure Asia Radiopharmaceuticals in Nuclear Medicine Production Volume Share by Type in 2020 (Volume)
Figure Asia Radiopharmaceuticals in Nuclear Medicine Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Radiopharmaceuticals in Nuclear Medicine Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type in 2020 (Million USD)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Production Volume Share by Type in 2020 (Volume)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type in 2020 (Million USD)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Production Volume Share by Type in 2020 (Volume)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type in 2025 (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Volume Share by Type in 2025 (Volume)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Value Share by Region in 2025 (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume Share by Region in 2025 (Volume)